Cardium Home
Overview
Board and Management
Management
Board of Directors
Corporate Governance
Stock Information
Stock Quote
Stock Chart
Historical Price Lookup
News Releases
2013
2012
2011
2010
Financial Reports
Calendar of Events
SEC Filings
Investor FAQ's
Fact Sheet
Presentations
Online Investor Kit
Request Information
Print Page
E-mail Page
E-mail Alerts
IR Contacts
News Releases
Receive E-mail Alerts
2013
|
2012
|
2011
| 2010
Date
Title
12/28/10
Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans
12/02/10
Cardium Reports on Exchange Listing Deficiency and Compliance Plan
11/29/10
Cardium Announces Market Launch of Linee(TM) - A Scientific Approach to Weight Management
11/18/10
Cardium Announces Co-Development and Strategic Licensing Agreement with BioZone Laboratories for Expansion of MedPodium Portfolio
11/15/10
Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development
11/09/10
Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments
11/08/10
Cardium to Present at the LifeTech Capital Miami Medical Investors Conference
11/04/10
Cardium Announces Launch of Its MedPodium Healthy Lifestyle Product Initiative and New Web Boutique
11/03/10
Cardium Awarded Grant Under Qualifying Therapeutic Discovery Project Program
10/13/10
Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process
09/29/10
Cardium Gains Exclusive Access to Novel Polymer-Based Nitric Oxide Technology for Expansion of Wound Healing Product Portfolio
09/20/10
Cardium to Present at 10th Annual Biotech in Europe Investor Forum
09/09/10
Cardium Announces Appexium(TM), a New Weight Loss Management Dietary Supplement to Expand MedPodium's Healthy Lifestyle Product Initiative
09/09/10
Cardium to Present at the Rodman & Renshaw 12th Annual Healthcare Investment Conference
09/09/10
Cardium to Present at the Rodman & Renshaw 12th Annual Healthcare Investment Conference
08/09/10
Cardium Reports on Second Quarter 2010 Financial Results and Recent Developments
07/07/10
Cardium Regains Listing Compliance With NYSE Amex
06/23/10
Cardium Reports on Compliance of NYSE Amex Exchange Listing Guidelines
06/14/10
Cardium Announces Dominique Dawes, Olympic Champion, as Web-Based Spokesperson for New MedPodium Podiatry-Focused Advanced Skin Care Product Line
06/10/10
Cardium Announces Master Services Agreement With bioRASI for Planned Late-Stage Clinical Study and Commercialization Activities for Generx Product Candidate in International Markets
06/08/10
Cardium Announces Collagen Supply Agreement with Devro Medical for Planned Market Launch of Excellagen Product Candidate and Reports on Further Positive Healing Effects
05/10/10
Cardium Reports on First Quarter 2010 Financial Results and Recent Developments
05/07/10
Cardium to Present at MDB Capital Group's 2010 Bright Lights Conference
03/16/10
Cardium Reports on Fourth Quarter and Year-End 2009 Financial Results and Recent Developments
03/15/10
Cardium Announces Closing of $11.3 Million in Registered Direct Equity Offering
03/09/10
Cardium Reports on Registered Direct Offering
03/08/10
Cardium's Exchange Listing Compliance Plan Accepted by NYSE AMEX
02/16/10
Cardium Announces Agreement With bioRASI to Advance and Broaden Clinical Development of Generx Product Candidate
01/26/10
Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell & Gene Therapy Forum
01/05/10
Cardium to Launch MedPodium(TM) Product Line Initially Covering Six New Advanced Foot Care Products for Podiatry Patients to Complement the Excellagen Platform
01/04/10
Cardium Reports on Exchange Listing With NYSE AMEX
back to top
